Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB

NCT02348177 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Acquired Immunodeficiency Syndrome
Tuberculosis

Interventions

DRUG: lopinavir with ritonavir in 1:1 ratio
DRUG: Lopinavir/ritonavir 4:1

Sponsor

Drugs for Neglected Diseases

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]